Triall: Blockchain to pave the way for new vaccines and therapeutics

Since 2020, the world has witnessed COVID-19 directly contribute to the rapid development of healthcare technologies. As the need for a bridge between healthcare and technology continues to grow, an array of initiatives take to the helm. Medical data sharing, treatment, vaccine developments, and other national healthcare initiatives continue to rise to the challenge. 

As the world emerges from the hardship of the pandemic, the renewed focus on digitization will help the healthcare industry respond faster to similar situations in the future. To facilitate this paradigm shift, Triall is pioneering a comprehensive digital ecosystem for ‘clinical trials’ — research studies that are necessary to evaluate the safety and efficacy of new vaccines and therapeutics before these can enter the market. 

Triall has developed a blockchain infrastructure that ensures medical data remains tamper-resistant, thus combatting a growing number of medical data integrity and auditability problems in today’s medical research environment. Additionally, their infrastructure enables a secure and efficient connection between the many systems and parties involved in clinical trials.

A Blockchain-Integrated Ecosystem for Clinical Trials

As the first digital ecosystem for clinical trials, Triall is building a blockchain-integrated platform built to serve and seamlessly connect clinical research professionals across the globe. Based on their experience of having managed 100+ international clinical trials, the Triall team is on a mission to enable smarter, safer, and more efficient clinical trials by applying blockchain-enabled technology where it truly adds value: for the assurance of medical data integrity, and the creation of a secured infrastructure through which clinical trial systems and their users can safely communicate and collaborate. Such promises to streamline modern-day clinical trial operations, accelerating the development of safe and affordable vaccines and therapeutics into society. 

The Triall Ecosystem is designed to serve the needs of all key stakeholders involved in clinical trials. Next to pharmaceutical developers and medical researchers, key stakeholders include clinical trial software providers, contract research organizations (CROs), infrastructure providers, and of course patients and trial participants. 

Triall’s ecosystem utilizes blockchain-enabled technologies and open standards such as decentralized identifiers (DIDs) and verifiable credentials (VCs). It combines these into an

API-driven infrastructure to connect all of these stakeholders, and to ensure data remains secure, authentic, and traceable. Triall Ecosystem solutions are offered in a secured cloud environment and integrated with existing blockchain platforms operated by cloud storage providers and node operators, who ensure the ecosystem remains decentralized, fast, safe, and reliable. 

As opposed to the modern field of medical research and healthcare technologies, Triall significantly improves upon the clinical trial domain. By bringing blockchain-enabled data verification as well as decentralized identity and access management utilities into the field, Triall significantly improves upon the latest innovations in clinical trials and aims to ensure that the day-to-day activities of medical researchers, patients, and other key stakeholders are eased, secured, and accelerated. 

Streamlining Clinical Trial Document Management 

Document management and recordkeeping are critical pain points within the clinical trial industry. Due to strict regulatory requirements, clinical trial researchers have to build a compulsory Trial Master File (TMF) to ensure compliance and facilitate the collection of documents that can easily number in the thousands. Without a compliant TMF, regulatory approval cannot be obtained, and as such, new medicine cannot enter the market.

Triall provides a pain-point-free electronic TMF alternative dubbed Verial eTMF. This user-centric document management solution expedites the TMF building process while ensuring integrity and structural reliability. Uniquely, Verial eTMF allows users to create verifiable proofs of the existence, integrity, and authenticity of clinical trial documents via irrefutable blockchain timestamping. 

This timestamping feature is unique in the market and promises to improve the speed and reliability of clinical trial processes, while also promising to reduce the burden of monitoring for auditors and regulators, as well as building trust among all clinical trial stakeholders. These benefits aim to satisfy regulatory requirements to a high standard without hampering or delaying existing clinical trial workflows. 

Verial eTMF v1.0 is currently used within several first commercial clinical trial projects, with more paying customers ready to be onboarded. Further improvements are currently being augmented, including AI-enabled automated document classification and blockchain-registered digital signatures. 

Managing Clinical Trials in Practice

Within the clinical trials industry, the critical need for unifying the plethora of function-specific clinical trial software (eClinical) solutions currently offered on the market continues to grow. This need is fueled by the demand for better visibility, increased project oversight, improved study analytics, and proactive risk mitigation. Triall addresses these demands by providing a range of APIs and through its application Triall Clinical Trial Management System (CTMS). 

Triall CTMS is a dashboard application that integrates and visualizes data recorded by separate eClinical solutions. This will provide clinical research professionals with near real-time overviews of all their clinical trial activities while ensuring traceability. 

The Triall CTMS dashboard will feature planning and oversight tools that support clinical research professionals with their decision-making capabilities. The dashboard allows faster and better-informed decisions in areas such as trial management, resource allocation, and risk-based monitoring. 

In parallel to Verial eTMF and Triall CTMS, Triall also offers APIs that enable third-party software providers to synergize with its blockchain infrastructure. By developing their own software solutions while also connecting with third-party solutions, Triall aims to gradually shape the world’s first blockchain-enabled digital ecosystem for clinical trials, allowing clinical trial systems and their users to act in concert. 

A Tokenized Light at the End of the Tunnel 

The Triall project takes a research-backed ecosystem approach that is tailored to the critical needs faced by clinical trial professionals today. The ecosystem is developed with the principles of the cryptocurrency industry in mind, incentivizing a diverse community of project investors and clinical trial stakeholders to create and capture value through tokenization. 

COVID-19 has gained global attention and awareness of healthcare systems and has demonstrated key areas for improvement. As we emerge from the global pandemic, Triall builds a strong community of synergic partners, advisors, investors, and stakeholders that pioneer the bridges between healthcare and crypto domains. 

To find out more about Triall’s tokenization model, or how it is bridging the gap between the healthcare and crypto domains, visit their main site here.

Disclaimer: This is a paid post and should not be treated as news/advice.